ロード中...

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial

AIM: To evaluate the efficacy and safety of insulin glargine 300 U/mL (Gla‐300) versus insulin degludec 100 U/mL (IDeg‐100) in predefined (</≥65 years) and post hoc (</≥70 years) age groups of people with type 2 diabetes (T2D) in the BRIGHT trial. MATERIALS AND METHODS: BRIGHT was the first he...

詳細記述

保存先:
書誌詳細
出版年:Diabetes Obes Metab
主要な著者: Bolli, Geremia B., Cheng, Alice, Charbonnel, Bernard, Aroda, Vanita R., Westerbacka, Jukka, Bosnyak, Zsolt, Boëlle‐Le Corfec, Emmanuelle, Rosenstock, Julio
フォーマット: Artigo
言語:Inglês
出版事項: Blackwell Publishing Ltd 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252805/
https://ncbi.nlm.nih.gov/pubmed/33687748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14372
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!